Data / Form D filings / Inso Biosciences Inc.
Inso Biosciences Inc.: Form D filings
Inso Biosciences Inc., a biotechnology company in Ithaca, NY, filed 2 Form D notices with the SEC between 2022 and 2026. The latest, on April 10, 2026, reports $750,000 sold of a $3 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 237 TOWER ROAD, ROOM 410 WEILL HALL MCGOVERN CENTER, Ithaca, NY, 14853
- Phone
- (479) 283-8428
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1906426
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 10, 2026 | New notice | $3,000,000 | $750,000 | $2,250,000 | 9 | Mar 3, 2026 | sec.gov |
| Feb 25, 2022 | New notice | $2,275,000 | $1,775,000 | $500,000 | 4 | Feb 11, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Harvey Chen Tian | Executive Officer, Director | |
| Adam Bisogni | Director |
Other biotechnology companies in New York that filed recently
- Swep Bio, Inc. $2.5 million · Oct 29, 2026
- Hypercell Technologies Inc. $3 million · Oct 14, 2026
- CAD Therapeutics, Inc. $4 million · Oct 2, 2026
- Vicora, Inc. $2.3 million · Sep 18, 2026
- GevRx Nutraceuticals, Inc. $300,000 · Sep 18, 2026
- Episteme Prognostics, Inc. $5.1 million · Sep 4, 2026
Every Form D from the week of Apr 6, 2026 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Inso Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.